Stock Earnings Stoke Therapeutics Inc (STOK) Becoming More Attractive for Investors In a filing, Stoke Therapeutics Inc revealed its CHIEF MEDICAL OFFICER Ticho Barry unloaded Company’s shares for reported $57724.0 on
Analysts Viewpoint Insider Selling: Ticho Barry, Stoke Therapeutics Inc [STOK] CHIEF MEDICAL OFFICER divested 4,503 shares Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its